We also assessed the correlation between BMI1 expression and immune checkpoint-related molecules, including PD-L1, Galectin 9, HVEM, and IDO1, all of which are important marker genes for cancer immune therapy [32]. The gene discussed is TNFRSF14; the disease is cancer.